IL157756A0 - Novel expression vectors - Google Patents

Novel expression vectors

Info

Publication number
IL157756A0
IL157756A0 IL15775602A IL15775602A IL157756A0 IL 157756 A0 IL157756 A0 IL 157756A0 IL 15775602 A IL15775602 A IL 15775602A IL 15775602 A IL15775602 A IL 15775602A IL 157756 A0 IL157756 A0 IL 157756A0
Authority
IL
Israel
Prior art keywords
vectors
present
expression vectors
provides
expression
Prior art date
Application number
IL15775602A
Other languages
English (en)
Original Assignee
Gene Stream Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Stream Pty Ltd filed Critical Gene Stream Pty Ltd
Publication of IL157756A0 publication Critical patent/IL157756A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Image Generation (AREA)
IL15775602A 2001-03-09 2002-03-08 Novel expression vectors IL157756A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27477001P 2001-03-09 2001-03-09
PCT/AU2002/000351 WO2002072844A1 (fr) 2001-03-09 2002-03-08 Nouveaux vecteurs d'expression

Publications (1)

Publication Number Publication Date
IL157756A0 true IL157756A0 (en) 2004-03-28

Family

ID=23049549

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15775602A IL157756A0 (en) 2001-03-09 2002-03-08 Novel expression vectors
IL157756A IL157756A (en) 2001-03-09 2003-09-04 Methods for assaying activity of trancriptional control elements

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL157756A IL157756A (en) 2001-03-09 2003-09-04 Methods for assaying activity of trancriptional control elements

Country Status (13)

Country Link
US (3) US7157272B2 (fr)
EP (1) EP1373528B1 (fr)
JP (2) JP2004530425A (fr)
KR (1) KR100917939B1 (fr)
CN (1) CN100471956C (fr)
AT (1) ATE404679T1 (fr)
AU (1) AU2002242474B2 (fr)
CA (1) CA2440148C (fr)
DE (2) DE02708018T1 (fr)
IL (2) IL157756A0 (fr)
NZ (1) NZ528000A (fr)
WO (1) WO2002072844A1 (fr)
ZA (1) ZA200306885B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598079B2 (en) 1998-12-24 2009-10-06 Novation Pharmaceuticals, Inc. Assay for identifying compounds which affect stability of mRNA
WO2002072844A1 (fr) * 2001-03-09 2002-09-19 Gene Stream Pty Ltd Nouveaux vecteurs d'expression
ATE464317T1 (de) 2001-06-05 2010-04-15 Curevac Gmbh Stabilisierte mrna mit erhöhtem g/c-gehalt für die gentherapie
DE60330489D1 (de) * 2002-09-16 2010-01-21 Promega Corp Schnell abgebaute reporter-fusionsproteine
DE102004042546A1 (de) * 2004-09-02 2006-03-09 Curevac Gmbh Kombinationstherapie zur Immunstimulation
AR053279A1 (es) * 2005-05-19 2007-04-25 Monsanto Technology Llc Regulacion post-transcripcional de la expresion genica
US20070212332A1 (en) * 2005-08-11 2007-09-13 Department Of Veterans Affairs Methods for accelerating bone repair
EP1760092A1 (fr) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. Système pour le criblage des cellules à haute expression d'une protéine d'intérêt
WO2007038757A2 (fr) * 2005-09-28 2007-04-05 Attagene Inc. Procedes et compositions d'evaluation non invasive d'une expression genique
DE102005046490A1 (de) * 2005-09-28 2007-03-29 Johannes-Gutenberg-Universität Mainz Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
US20070245258A1 (en) * 2006-04-13 2007-10-18 Codman Neuro Sciences Sàrl Graphical user interface of an external control device for controlling an implantable medical device while minimizing human error
EP2121921A4 (fr) * 2006-12-13 2010-08-04 Idiverse Inc Nouveaux gènes et molécules d'arn qui confèrent une tolérance à la contrainte
WO2008076844A2 (fr) * 2006-12-13 2008-06-26 Unl Technology Development Corporation Nouveaux gènes et molécules d'arn conférant une tolérance au stress
AU2007335194B2 (en) 2006-12-21 2014-01-23 Gene Stream Pty Ltd Bioluminescent assays utilising secreted luciferases
US20100239502A1 (en) * 2007-07-11 2010-09-23 Koninklijke Philips Electronics N.V. In vivo expression analysis using ultrasound-induced transfection of reporter constructs
US20090111099A1 (en) * 2007-10-27 2009-04-30 Yongsheng Ma Promoter Detection and Analysis
US20110071047A1 (en) * 2007-10-27 2011-03-24 O.D. 260 Inc. Promoter detection and analysis
KR101204895B1 (ko) 2010-01-27 2012-11-26 단국대학교 산학협력단 Ｐｒｃ１ 유전자 프로모터의 삭제변이 프로모터를 함유하는 암세포 특이적 발현벡터
EP3578205A1 (fr) 2010-08-06 2019-12-11 ModernaTX, Inc. Compositions pharmaceutiques a base d'acides nucléiques modifiés et leur utilisation medicale
CN104531812A (zh) 2010-10-01 2015-04-22 现代治疗公司 设计核酸及其使用方法
WO2012071631A1 (fr) 2010-12-03 2012-06-07 Gene Stream Pty Ltd Molécules électroluminescentes améliorées
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
ES2911677T3 (es) 2011-10-03 2022-05-20 Modernatx Inc Nucleósidos, nucleótidos y ácidos nucleicos modificados, y sus usos
RS63244B1 (sr) 2011-12-16 2022-06-30 Modernatx Inc Kompozicije modifikovane mrna
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US20140010861A1 (en) 2012-04-02 2014-01-09 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
LT2922554T (lt) 2012-11-26 2022-06-27 Modernatx, Inc. Terminaliai modifikuota rnr
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
CN104099357B (zh) * 2013-04-12 2016-09-21 中国科学院上海生命科学研究院 检测蛋白质稳定性的方法及其应用
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
EP3452101A2 (fr) * 2016-05-04 2019-03-13 CureVac AG Arn codant pour une protéine thérapeutique
MX2018015540A (es) 2016-06-20 2019-04-11 Janssen Vaccines & Prevention Bv Promotor bidireccional potente y equilibrado.
EP3506916B1 (fr) 2016-09-01 2021-04-07 Chimera Bioengineering Inc. Lymphocytes t car optimisés avec de l'or
JP2021518747A (ja) * 2018-02-13 2021-08-05 キメラ・バイオエンジニアリング，インコーポレーテッド Ｒｎａ不安定化エレメントを使用した遺伝子発現の調整
KR102490457B1 (ko) * 2019-11-26 2023-01-19 한국생명공학연구원 단백질 발현용 mRNA 구조체 및 이의 용도
WO2022204471A1 (fr) * 2021-03-26 2022-09-29 Ptc Therapeutics Inc. Régulation de l'expression de transgènes au moyen d'un commutateur d'épissage inductible à petites molécules
WO2022250430A1 (fr) * 2021-05-25 2022-12-01 한국생명공학연구원 Procédé de préparation d'arnm pour exprimer une protéine, et utilisation de l'arnm ainsi préparé

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163212C (fr) * 1993-05-18 2004-07-13 Ahmed Abdullah Azad Composes therapeutiques
US5464758A (en) * 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5587300A (en) * 1994-04-26 1996-12-24 Wisconsin Ulumni Research Foundation Method to increase regulatory molecule production
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5625048A (en) * 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5777079A (en) * 1994-11-10 1998-07-07 The Regents Of The University Of California Modified green fluorescent proteins
US5804387A (en) * 1996-02-01 1998-09-08 The Board Of Trustees Of The Leland Stanford Junior University FACS-optimized mutants of the green fluorescent protein (GFP)
EP1484409B1 (fr) * 1996-12-16 2009-04-08 Eisai R&D Management Co., Ltd. Construction d'AND comprenant un gène de résistance à un médicament et un gène étranger
US6231880B1 (en) * 1997-05-30 2001-05-15 Susan P. Perrine Compositions and administration of compositions for the treatment of blood disorders
EP1021549A2 (fr) * 1997-09-19 2000-07-26 Sequitur, Inc. THERAPIES GENIQUES A BASE D'ARNm SENS
US6130313A (en) * 1997-10-02 2000-10-10 Clontech Laboratories, Inc. Rapidly degrading GFP-fusion proteins
US6306600B1 (en) * 1998-04-17 2001-10-23 Clontech Laboratories, Inc. Rapidly degrading GFP-fusion proteins and methods of use
US5965421A (en) * 1997-11-26 1999-10-12 Human Genome Sciences, Inc. Human IRAK-2
JPH11266872A (ja) * 1998-03-20 1999-10-05 Suntory Ltd ＮＦ−κＢの活性化を抑制する物質のスクリーニング方法
US20040002056A1 (en) * 1998-05-12 2004-01-01 Lorens James B. Methods of screening for bioactive agents using cells transformed with self-inactivating viral vectors
US6307123B1 (en) * 1998-05-18 2001-10-23 Dekalb Genetics Corporation Methods and compositions for transgene identification
AU779438B2 (en) * 1998-12-24 2005-01-27 Novation Pharmaceuticals Inc. Compounds which affect mRNA stability and uses therefor
GB9828709D0 (en) * 1998-12-24 1999-02-17 Novartis Ag Assay
US20020102638A1 (en) * 2000-01-31 2002-08-01 Rosen Craig A. Nucleic acids, proteins, and antibodies
US6841362B1 (en) * 2000-02-29 2005-01-11 The Trustees Of Columbia University In The City Of New York Melanoma differentiation associated gene-7 promoter and uses thereof
AU2001257428A1 (en) * 2000-04-28 2001-11-12 Message Pharmaceuticals, Inc. Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
WO2002072844A1 (fr) * 2001-03-09 2002-09-19 Gene Stream Pty Ltd Nouveaux vecteurs d'expression
EP2718441A1 (fr) * 2011-04-20 2014-04-16 King Faisal Specialist Hospital And Research Centre Système de fluorescence d'origine cellulaire à élément de réponse à de multiples interférons et virus
US20180305776A1 (en) * 2017-04-20 2018-10-25 The Board Of Trustees Of The Leland Stanford Junior University Myc-reporters, cells containing myc-reporters and methods of use thereof

Also Published As

Publication number Publication date
EP1373528B1 (fr) 2008-08-13
AU2002242474B2 (en) 2004-05-20
EP1373528A4 (fr) 2004-12-29
US9994858B2 (en) 2018-06-12
US20040209274A2 (en) 2004-10-21
US20040115704A1 (en) 2004-06-17
US20180305705A1 (en) 2018-10-25
US20070298417A1 (en) 2007-12-27
KR100917939B1 (ko) 2009-09-21
DE02708018T1 (de) 2004-09-30
JP2011015685A (ja) 2011-01-27
CA2440148C (fr) 2012-07-10
ZA200306885B (en) 2009-03-25
WO2002072844A1 (fr) 2002-09-19
IL157756A (en) 2010-12-30
EP1373528A1 (fr) 2004-01-02
KR20030092013A (ko) 2003-12-03
JP2004530425A (ja) 2004-10-07
CN100471956C (zh) 2009-03-25
NZ528000A (en) 2005-09-30
CN1503844A (zh) 2004-06-09
CA2440148A1 (fr) 2002-09-19
ATE404679T1 (de) 2008-08-15
DE60228212D1 (de) 2008-09-25
US7157272B2 (en) 2007-01-02

Similar Documents

Publication Publication Date Title
ZA200306885B (en) Novel expression vectors
WO2004009796A3 (fr) Systeme a un seul promoteur pour la production de cassettes d'expression d'arnsi et genotheque d'expression reposant sur l'utilisation d'un lieur en epingle a cheveux d'amorce de polymerase
ATE440950T1 (de) Konstrukte und verfahren zur regulation der genexpression
EP1824977A4 (fr) Nouvel acide nucleique de promoteur issu de la bacterie du genre corynebacterium, cassette d'expression contenant le promoteur et vecteur contenant la cassette, cellule hote comprenant le vecteur et procede d'expression d'un gene au moyen de la cellule
HK1027375A1 (en) Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
HUP0402271A2 (hu) Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek
IN2014DN02483A (fr)
WO2003089598A3 (fr) Polypeptides a activite xyloglucanase, et acides nucleiques codant ceux-ci
WO2004009794A3 (fr) Nouvelles banques genomiques de petits fragments d'arn interferents et procedes de production et d'utilisation de ces banques
AU2001242299A1 (en) Fungal transcriptional activator useful in methods for producing polypeptides
DK0981631T3 (da) Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme
AU6724794A (en) GRB3-3 gene, its variants and their uses
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
AU2003260200A8 (en) Reversible, parallel and multitask cloning method and kit
TW200510460A (en) Antimicrobial polypeptides
TW200502253A (en) Antimicrobial polypeptides
DE60332213D1 (de) Identifikation von 3-ketosteroid 9-alfa-hydroxylase genen und blockierte mikroorganismen in 3-ketosteroid 9-alfa-hydroxylase aktivität
DE60130465D1 (de) Mutierte muskelspezifische enhancer
ATE304591T1 (de) Nicht-bakterielles klonierungssystem zur verabreichung und expression von nukleinsäuren
DK1226236T3 (da) Polypeptider, der har glucanotransferase-aktivitet, og nucleinsyrer, som koder disse
AU2001276385A1 (en) Nucleotide sequences which code for the lysr3 gene
MXPA05008925A (es) Ciclooxigenasa-3 humana y usos de la misma.
AU2001287860A1 (en) Transglutaminase gene products
TW200512294A (en) DNA molecule encoding transglutaminase, transglutaminase, expression vector containing the sequence and cell containing the expression vector
WO2002059371B1 (fr) Emplacement et fonction de proteines de liaison a l'adn a l'echelle du genome